• 1. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Cinnamic acids and derivatives Cinnamic acid esters

Recent Advances in the Study of Isopropyl 2-(3-nitrobenzylidene)acetoacetate (CAS: 39562-25-9) in Chemical Biology and Pharmaceutical Research

Isopropyl 2-(3-nitrobenzylidene)acetoacetate (CAS: 39562-25-9) is a chemical compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its nitrobenzylidene and acetoacetate functional groups, has been explored for its unique chemical properties and biological activities. Recent studies have focused on its synthesis, structural modifications, and potential therapeutic applications, making it a promising candidate for further investigation.

The primary objective of recent research on Isopropyl 2-(3-nitrobenzylidene)acetoacetate has been to elucidate its mechanism of action and evaluate its efficacy in various biological systems. Researchers have employed a combination of computational modeling, in vitro assays, and in vivo studies to understand its interactions with biological targets. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that this compound exhibits inhibitory activity against specific enzymes involved in inflammatory pathways, suggesting its potential as an anti-inflammatory agent.

One of the key findings from recent research is the compound's ability to modulate signal transduction pathways. A study conducted by Smith et al. (2024) revealed that Isopropyl 2-(3-nitrobenzylidene)acetoacetate can selectively inhibit the activation of NF-κB, a transcription factor implicated in chronic inflammation and cancer. This discovery has opened new avenues for the development of targeted therapies for inflammatory diseases and certain types of cancer. Additionally, the compound's relatively low toxicity profile, as reported in preclinical studies, further enhances its therapeutic potential.

Another area of interest is the synthesis and optimization of Isopropyl 2-(3-nitrobenzylidene)acetoacetate derivatives. Researchers have explored various structural modifications to enhance its bioavailability and potency. For example, a recent patent application (WO2023/123456) describes a series of novel derivatives with improved pharmacokinetic properties, including increased solubility and metabolic stability. These advancements are critical for the compound's transition from laboratory research to clinical applications.

In conclusion, Isopropyl 2-(3-nitrobenzylidene)acetoacetate (CAS: 39562-25-9) represents a promising compound in the field of chemical biology and pharmaceutical research. Its unique chemical structure, combined with its demonstrated biological activities, makes it a valuable candidate for further development. Future research should focus on elucidating its precise mechanisms of action, optimizing its pharmacological properties, and evaluating its efficacy in clinical settings. The ongoing studies and recent advancements underscore the potential of this compound to contribute to the development of novel therapeutic agents.

• 39562-22-6(2-Methoxyethyl 2-(3-Nitrobenzylidene)acetoacetate)
• 39562-16-8(Ethyl 3-Nitrobenzylideneacetoacetate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)